pGL4.23 C3_5 Citations (2)
Originally described in: Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants.Pasquali L, Gaulton KJ, Rodriguez-Segui SA, Mularoni L, Miguel-Escalada I, Akerman I, Tena JJ, Moran I, Gomez-Marin C, van de Bunt M, Ponsa-Cobas J, Castro N, Nammo T, Cebola I, Garcia-Hurtado J, Maestro MA, Pattou F, Piemonti L, Berney T, Gloyn AL, Ravassard P, Gomez-Skarmeta JL, Muller F, McCarthy MI, Ferrer J Nat Genet. 2014 Feb;46(2):136-43. doi: 10.1038/ng.2870. Epub 2014 Jan 12. PubMed Journal
Articles Citing pGL4.23 C3_5
| Articles |
|---|
| A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors. Zhao H, Davies TJ, Ning J, Chang Y, Sachamitr P, Sattler S, Fairchild PJ, Huang FP. Cell Reprogram. 2015 Feb;17(1):7-18. doi: 10.1089/cell.2014.0046. Epub 2014 Dec 30. PubMed |
| The chicken chorioallantoic membrane model for isolation of CRISPR/cas9-based HSV-1 mutant expressing tumor suppressor p53. Kelishadi M, Shahsavarani H, Tabarraei A, Shokrgozar MA, Teimoori-Toolabi L, Azadmanesh K. PLoS One. 2023 Oct 20;18(10):e0286231. doi: 10.1371/journal.pone.0286231. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.